A Pivotal, Multicentre, Double-Blind, Double-Dummy, Randomised Trial on the Contraceptive Efficacy, Tolerability and Safety of LF111 (Drospirenone) Over 9 Cycles in Comparison With Desogestrel 0.075 mg.

Trial Profile

A Pivotal, Multicentre, Double-Blind, Double-Dummy, Randomised Trial on the Contraceptive Efficacy, Tolerability and Safety of LF111 (Drospirenone) Over 9 Cycles in Comparison With Desogestrel 0.075 mg.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2016

At a glance

  • Drugs Desogestrel (Primary) ; Drospirenone (Primary)
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Leon Farma
  • Most Recent Events

    • 19 May 2012 Additional trial locations (Austria, Spain) added as reported by European Clinical Trials Database.
    • 22 Mar 2012 Additional trial location (Hungary) added as reported by European Clinical Trials Database.
    • 07 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top